Abstract:Cisplatin has been used to treat various types of cancers for over 30 years, however, a number of serious side-effects of cisplatin have stimulated the quest for other metal-based anticancer agents. Iridium complexes are generally thought to be too inert to possess high reactivity, and therefore, there are only a few previous reports of the antitumour activity of iridium complexes. In this thesis a wide range of organometallic IrIII cyclopentadienyl complexes of the type [(η5-Cpx)Ir(XY)Cl]0/+ (where Cpx = pentamethylcyclopentadienyl (Cp*), tetramethyl(phenyl)cyclopentadienyl (Cpxph) or tetramethyl(biphenyl)cyclopentadienyl (Cpxbiph), XY = N,N-, N,O- or C^N-chelating ligand) has been synthesised and characterised. All the complexes hydrolyse rapidly in aqueous solution. Complexes with N,N-chelating ligands readily form adducts with 9-ethylguanine but not 9-ethyladenine; C^N- or N,O-chelated complexes bind to both purines. Guanine residues are preferential binding sites for 1,10-phenanthroline complexes on plasmid DNA. Replacement of the neutral N,N-bound chelating ligand by the negatively-charged C,N-bound analogues can improve biological activity. In addition, cytotoxic potency towards A2780 human ovarian cancer cells increases with phenyl substitution on Cp*: Cpxbiph > Cpxph > Cp*. This can be rationalised by increased hydrophobicity with more extended phenyl ring, resulting in increased cellular uptake and increased intercalative ability. Notably, several complexes exhibited submicromolar anticancer activity. The interconversion of 1,4-NADH and NAD+ through hydride-transfer reactions in the presence of cyclopentadienyl IrIII aqua complexes was studied. It is shown that the IrIII aqua complexes not only converts NAD+ to 1,4-NADH using formate as the hydride source, but can also catalyse the reverse reaction with hydride donation from 1,4-NADH to a iridium centre, recovered by protonation of bound hydride with generation of H2. This work demonstrates how the aqueous chemistry, nucleobase binding and anticancer activity of the IrIII cyclopentadienyl complexes can be controlled and fine-tuned by the modification of the chelating and cyclopentadienyl ligands. The results suggest that this new class of organometalic Ir(III) complexes is well suited for development as anticancer agents.

Unusual Dimeric Chemical Structure For A Carboplatin Analogue As A Potential Anticancer Complex

Synthesis and Anticancer Activity of [2-Hydroxy-1,3-diaminopropane-κ2n,n′] Platinum(ii) Complexes

Synthesis and Biological Activity of Binuclear Platinum Complexes Containing Two Monofunctional Cis-[Pt(Nh3)(2)Cl](+) Units Bridged by 4,4 '-Dipyridyl Selenides or Sulfides

Synthesis, Reactivity Studies and Cytotoxicity of Two Iodidoplatinum(II) Complexes. Does Photoactivation Work?

Novel antitumor dinuclear platinum (II) complexes with a new chiral tetradentate ligand as the carrier group

Design, Synthesis and Anticancer Activity of Diam(m)ine Platinum(ii) Complexes Bearing a Small-Molecular Cell Apoptosis Inducer Dichloroacetate

Dithiocarbazate–Fe III , −Co III , −Ni II , and −Zn II Complexes: Design, Synthesis, Structure, and Anticancer Evaluation

Novel Cisplatin-Type Platinum Complexes and Their Cytotoxic Activity

Structural Studies of Dicycloplatin-an Antitumor Supramolecule

Antitumor Active Monofunctional Platinum(ii) Complexes: Synthesis, Structural Characterization and Reactivity Towards Biomolecules

Synthesis and Antitumor Activity of Dinuclear Platinum Complexes with (1(i)R, 1(ii)R, 2(i)R, 2(ii)R)-N-i,N-ii-(1, 3-Phenylenebis(methylene))dicyclohexane-1, 2-diamie as the Ligand

Structural Evidence For The Facile Chelate-Ring Opening Reactions Of Novel Platinum(Ii)-Pyridine Carboxamide Complexes

Potent Anticancer Activity and Possible Low Toxicity of Platinum(ii) Complexes with Functionalized 1,1-Cyclobutanedicarboxylate As a Leaving Ligand.

Synthesis, crystal structures and anticancer activity of pt(II) complexes with two sterically hindered 2-methylpyridine groups as the carrier

Synthesis and Structure of Platinum(ii) Complexes Containing an Asymmetric Chelating Diamine 2-Morpholinoethylamine As the Carrier

Synthesis and in vitro antiproliferative activity of platinum(II) complexes with N-monoalkyl 1R,2R-diaminocyclohexane as ligands.

Organometallic Iridium Anticancer Complexes

Organometallic Binuclear Pd(II) Complex: Synthesis, Crystal Structure and In-Vitro Antitumor Activity Study

Multinuclear Anticancer Platinum Complexes

Decoration of Cisplatin on 2D Metal-Organic Frameworks for Enhanced Anticancer Effects through Highly Increased Reactive Oxygen Species Generation.

Ferrocene-modified Half-Sandwich Iridium(iii) and Ruthenium(ii) Propionylhydrazone Complexes and Anticancer Application